Nivata IPO Market Data
Moneyview
IPO GMP & Details
Check Moneyview IPO GMP and its recorded history, price band, issue dates, total subscription, lot size and listing date. Unofficial GMP is not a listing forecast.
At a glance
Moneyview IPO details
Unofficial market context
Moneyview IPO GMP trend
The chart shows recent GMP movement over time. GMP is unofficial and should not be treated as a listing-price forecast or recommendation.
Latest chart observation+₹14.60
Change across recorded history₹0
Recorded observations2
Current GMP reference price₹48.60
+₹14.60+₹14.60
1 Oct2 Oct
| Observation | GMP | Change | Reference price |
|---|---|---|---|
| 2 Oct 2026, 5:25 AM | +₹14.60 | ₹0 | ₹48.60 |
| 1 Oct 2026, 2:32 PM | +₹14.60 | — | ₹48.60 |
Post-listing factual comparisonLast recorded GMP +₹14.60 · Last GMP reference price ₹48.60 · Actual listing price ₹55
The actual listing price is shown when available. The comparison is factual and does not imply future performance.
Issue schedule & market details
Moneyview IPO key data
These are structured market-data fields. Missing values are left blank rather than estimated.
Issue typeMainboard
ExchangeBSE, NSE
Price band₹32 – ₹34
Lot size441 shares
Issue size₹1091.68 Cr
Open date24 Sep 2026
Close date28 Sep 2026
Listing date1 Oct 2026
Overall subscription98.46× subscribed
Last recorded GMP+₹14.60
GMP reference price₹48.60
Actual listing price₹55
Quick facts
Moneyview IPO FAQs
When does the Moneyview IPO open and close?
The opening date is 24 Sep 2026. The closing date is 28 Sep 2026.
When is the Moneyview IPO listing date?
The currently recorded listing date is 1 Oct 2026. The timetable can change if the issue schedule is revised.
What is the Moneyview IPO price band?
The currently recorded price band is ₹32 – ₹34.
What is the Moneyview IPO lot size?
The recorded lot size is 441 shares. Review the official issue terms before applying.
What is the Moneyview IPO subscription?
Nivata currently records overall issue subscription at 98.46 times. This is not an allotment probability.
This page contains factual IPO schedule, pricing, subscription, listing and GMP information. It does not contain an IPO research article and does not provide a recommendation, rating, target price, valuation conclusion, expected return, listing forecast, allotment probability or a view on whether to participate in the issue.